Hepatic Impairment Recruiting Phase 1 Trials for Enasidenib (DB13874)

Also known as: Liver impairment / Diseases of liver (K70-K77) / Hepatic pathology / Fector hepaticus / [X]Diseases of the liver / Hepatopathy / Hepatic disease NOS / Hepatic disorder (NOS) / Disorder hepatic / Hepatic disorder NOS / Disease hepatocellular / Disorder liver / Hepatic disease / Hepatic disease (NOS) / Liver disorder / Liver Diseases / Unspecified disorder of liver

IndicationStatusPhase
DBCOND0031585 (Hepatic Impairment)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03290443A Study to Assess the Pharmacokinetics of Enasidenib (CC-90007) in Subjects With Moderate and Severe Hepatic Impairment.Treatment